ArcherDX rakes in $60 mln Series B

Boulder-based ArcherDX Inc, a molecular technology company focused on genomic medicine, has raised $60 million in Series B financing. Perceptive Advisors led the round with participation from other backers that included PBM Capital, Boulder Ventures, Longwood Fund and Peierls Foundation. Evercore Group LLC acted as financial adviser to ArcherDX on the transaction.

Source: Press Release